Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, ORTHOFIX MEDICAL INC. reported revenue of $822M, up 2.9% year over year. Operating margin was -9.9% and net margin -11.2%, on a free-cash-flow margin of -0.2% with capital expenditure at 4.2% of revenue. Every figure is computed directly from OFIX's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $822M | -9.9% | -11.2% |
| FY2024 | $799M | -10.6% | -15.8% |
| FY2023 | $747M | -18.6% | -20.3% |
| FY2022 | $461M | -2.9% | -4.3% |
| FY2021 | $464M | -1.8% | -8.3% |
How does OFIX compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.